Lanreotide Acetate
Lanreotide Acetate is an active ingredient in 13 FDA-listed drug products sold under 2 names.
Drugs containing Lanreotide Acetate
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 70121-2517 | Lanreotide Acetate Injection | 120 mg/.5mL | Amneal Pharmaceuticals LLC |
| 69097-880 | Lanreotide Acetate Injection | 60 mg/.2mL | Cipla USA Inc. |
| 69097-908 | Lanreotide Acetate Injection | 90 mg/.3mL | Cipla USA Inc. |
| 69097-870 | Lanreotide Acetate Injection | 120 mg/.5mL | Cipla USA Inc. |
| 69097-907 | Lanreotide Acetate Injection | 60 mg/.2mL | Cipla USA Inc. |
| 69097-890 | Lanreotide Acetate Injection | 90 mg/.3mL | Cipla USA Inc. |
| 69097-906 | Lanreotide Acetate Injection | 120 mg/.5mL | Cipla USA Inc. |
| 76282-718 | Lanreotide Acetate Injection | 60 mg/.2mL | EXELAN PHARMACEUTICALS, INC. |
| 76282-719 | Lanreotide Acetate Injection | 90 mg/.3mL | EXELAN PHARMACEUTICALS, INC. |
| 76282-720 | Lanreotide Acetate Injection | 120 mg/.5mL | EXELAN PHARMACEUTICALS, INC. |
| 15054-1120 | Somatuline Depot Injection | 120 mg/.5mL | Ipsen Biopharmaceuticals, Inc. |
| 15054-1090 | Somatuline Depot Injection | 90 mg/.3mL | Ipsen Biopharmaceuticals, Inc. |
| 15054-1060 | Somatuline Depot Injection | 60 mg/.2mL | Ipsen Biopharmaceuticals, Inc. |